This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

3-Year Outcome for Both Structure and Function

Creig S. Hoyt, MD

Arch Ophthalmol. 1993;111(3):319-320.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The outcome data of the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity¹ at 3-year follow-up reported herein are encouraging and important for all ophthalmologists involved in the treatment of at-risk infants. At a time when the phrase "randomized, prospective, multicenter trial" has practically become a shibboleth in the grantsmanship arena, it is gratifying to see the wealth of information that can be obtained from a rigorously conducted trial. Although some have advocated cryotherapy for the treatment of retinopathy of prematurity,² this multicenter trial provides us with details not available elsewhere. The investigators and committees of this study should be congratulated for their attention to detail in performing this trial.

See also pp 339 and 345.

Where are we now in our understanding of retinopathy of prematurity and its treatment?

It is now clearly proven that cryotherapy is effective in treating some, but not all, "at-risk infants" as . . . [Full Text PDF of this Article]

Author Affiliations
San Francisco, Calif

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?